Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Towards precision medicine in childhood leukemia--insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia.

Cancer letters - 28 Sept 2014

Izraeli Shai, Shochat Chen, Tal Noa, Geron Ifat

Abstract excerpt

The successful therapy of childhood leukemia has been characterized by careful personalized adaptation of therapy by risk stratification. Yet almost all drugs are relatively non-specific. To achieve greater precision in therapy, druggable targets and specific targeting drugs are necessary. Here w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Precision Medicine
Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Cytokine

Share to Signal Transduction

Source

Identifiers

PMID: 24569093
DOI: 10.1016/j.canlet.2014.02.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24569093-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Towards precision medicine in childhood leukemia--insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia.PMID 24569093Read ↗

Pediatric acute leukemia therapies informed by molecular analysis of high-risk disease.Semantic proximity Read ↗

Precision Medicine for Acute Lymphoblastic Leukemia in Children: A ReviewSemantic proximity Read ↗

Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?Semantic proximity Read ↗

Therapies on the horizon for childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Targeting signaling pathways in acute lymphoblastic leukemia: new insightsSemantic proximity Read ↗

Genomic analysis drives tailored therapy in poor risk childhood leukemia.Semantic proximity Read ↗

Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.Semantic proximity Read ↗

Novel clinical trials for pediatric leukemias: lessons learned from genomic analyses.Semantic proximity Read ↗

Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomesSemantic proximity Read ↗

The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Therapeutic targeting of IL-7Rα signaling pathways in ALL treatmentSemantic proximity Read ↗

Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.